[1] Isobe Y,Yamamoto Y,Nishiyama Y,et al.Markedly increased accumulation of Tc-99m DT PA in a patient with neurofibromatosis[J].Clin Nucl Med,1998,23(8):557-559.
[2] Suga K,Hirabayshi A,Kishimoto K,et al.Tc-99m DTPA used as reference imaging to evaluate the distri-bution of other tumor-seeking tracers in tumors associ-ated with neurofibromatosis[J].Clin Nucl Med,1999,24(6):435-439.
[3] Miyazawa N,Koizumi K,Mitsuka S,et al.Discrepan-cies in brain perfusion SPECT findings between Tc-99m HM PAO and Tc-99m ECD:evaluation using dy-namic SPECT in patients with hyperemia[J].Clin Nucl Med,1998,23(10):686-690.
[4] Hashimoto J,Sasaki T,Itoh Y,et al.Brain SPECT imaging using three different tracers in subacute cere-bral infarction[J].Clin Nucl Med,1998,23(5):275-277.
[5] Lauriero F,Rubini G,Addabbo F,et al.I-131 MIBG scintigraphy of neuroectodermal tumors.Comparison between I-131 MIBG and In-111 DTPA-octreotide[J].Clin Nucl Med,1995,20(3):243-249.
[6] Flores LG,Jinnouchi S,Nagamachi S,et al.rCBF in neurodegenerative diseases as estimated by the autora-diographic (ARG) method and delayed I-123-IMP studies[J].Ann Nucl Med,1999,13(5):281-285.
[7] Hayashida K,Fukuchi K,Hasegawa Y,et al.Viable tis-sue in an area of severely reduced perfusion demon-strated with I-123 iomazenil brain SPECT imaging of benzodiazepine receptors[J].Clin Nucl Med,1999,24(8):576-578.
[8] Dresel S,Tatsch K,Dahne I.Iodine-123-iodobenzamide SPECT assessment of dopamine D2 receptor occupancy in riperidone-treated schizophrenic patients[J].J Nucl Med,1998,39(7):1138-1142.
[9] Dresel S,Mager T,Rossmuller B,et al.In vivo effects of olanzapine on striatal dopamine D(2)/D(3) receptor binding in schizophrenic patients:an iodine-123 iodobenzamide single-photon emission tomography study[J].Eur J Nucl Med,1999,26(8):862-868.
[10] Facco E,Munari M,Behr AU,et al.Assessment of brain perfusion in coma and comparison between SPECT and CT scan data:preliminary report[J].Neu-rol Res,1998,20(Suppl 1):S40-S43.
[11] Iranzo A,Marti FJ,Domingo P,et al.Absence of Thal-lium-201 brain uptake in progressive multifocalleukoencephalopathy in AIDS patients[J].Acta Neurol Scand,1999,100(2):102-105.
[12] Ronin B,Marsden PK,O'Doherty M J.Are restrictions to behaviour of patients required following fluorine-18 fluorodexyglucose positron emission tomographic stud-ies?[J].Eur J Nucl Med,1999,26(2):121-128.
[13] Seabold JE,Simonson TM,Weber PC,et al.Cranial os-teomyelitis:diagnosis and follow-up with In-111 white blood cell and Tc-99m methylene diphosphonate bone SPECT,CT,and MR imaging[J].Radiology,1995,196(3):779-788.
[14] Stokking R,Zuiderveld KJ,Hulshoff PHE,et al.Nor-mal fusion for three-dimensional integrated visualiza-tion of SPECT and magnetic resonance brain images[J].J Nucl Med,1997,38(4):624-629.
[15] Graham LS.Quality control for SPECT systems[J].Radiographics,1995,15(6):1471-1481.
[16] Williams BS,Hinkle GH,Lamatrice RA,et al.Techni-cal considerations for acquiring and processing Indium-111 capromab pendetide images[J].JNucl Med Tech-nol,1997,25(3):205-216.
[17] Barnes A,Dai D,Montaldi D,et al.Image quality ver-sus statistical power[J].Nucl Med Commun,1997,18(12):1155-1160.